Navigation Links
Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
Date:11/6/2007

MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people with diabetes and/or high blood pressure -- the two leading causes of chronic kidney disease (CKD) -- are not receiving recommended tests to identify this disease early, when medical treatment can slow or halt disease progression, according to the latest Quest Diagnostics Health Trends(TM) Report. In addition, the report's findings suggest that patients with early-stage CKD are not being well managed for contributing diseases, such as diabetes and hyperlipidemia.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/quest/30595/

These findings, released today by Quest Diagnostics Incorporated (NYSE: DGX) following the National Kidney Foundation's consensus conference, Cardio-Kidney Diabetes ... The Triple Threat, are based on diagnostic test results from more than 5 million patients in the Quest Diagnostics database.

The Quest Diagnostics Health Trends(TM) Report, "An Analysis of Chronic Kidney Disease in the U.S.," is the largest assessment of the relationships among CKD, cardiovascular disease (CVD) and diabetes. Two analyses were conducted. The first, performed on test results from 2005 to 2006, showed that a majority of patients with evidence of kidney disease as well as diabetes and/or high blood pressure (hypertension) did not receive a widely available, inexpensive and non-invasive urine test to check for albumin, or protein in the urine, in the previous 12 months. Specifically, 90 percent of patients with hypertension and CKD, 60 percent of patients with diabetes and CKD, and 52 percent of patients with diabetes, hypertension and CKD did not receive the microalbumin test during this time period.

The study suggests a failure to implement evidence-based guidelines issued by the National Kidney Foundation (NKF), American Diabetes Association (ADA), National Institutes of
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
6. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
7. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, THOUSANDOAKS,Calif.,Nov.23/PRNewswire-Fir...ScripAwards,winningforBestOverallPipelineandforBes...monyinLondon. ,, TheBestOverallPipelineawardwas...ity,noveltyandmarketpotentialofthecompany,spipelin...s.Accordingtothejudges,Amgen,spipelineisnotablefor...
(Date:11/23/2009)...,, NEWYORK,Nov.23/PRNewswire/--Reportlinker....einitscatalogue. ,, IndiaDentalDevicesInvestme... http://www.reportlinker.com/p0164620/India-Denta...recasts-to-2015.html#utm_source=prnewswire&utm...Description ,, IndiaDentalDevicesInvestmentOpp...
(Date:11/23/2009)...,, ,, BOSTON,Nov.23/PRNewswire-FirstCa...nformationmanagementsolutions,todayannouncedthatit...nsatthe2009RadiologicalSocietyofNorthAmerica(RSNA)....AMICASwillbeintheNorthHallinbooth#7124. ,, (Lo...MICASLOGO ) ,, "Giventhenationalconversationabo...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 13AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3Biologist discovers pink winged moth in Chiracahua Mountains 8779 1Biologist discovers pink winged moth in Chiracahua Mountains 8779 2CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 1CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 2CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 3CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 4CardioDynamics Agrees to be Acquired by SonoSite for 241 35 Per Share 12547 5Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 1Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 2Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 3Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 4Masimo Debuts New Rad 8 28R 29 Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009 48377 5
...tion with UC San Diego , , NOVATO, Calif., Feb. 5...ompany") (OTC Bulletin Board: RPTP), today announc...se 2a open-label clinical trial to evaluate cystea...sed with non-alcoholic steatohepatitis ("NASH"). N...unts for approximately 10% of newly diagnosed case...
...ited (ASX: CYT) has successfully concluded dose-es... company,s anticancer vascular-disrupting agent (V...nd tolerability study have been achieved. These we...nd the dose-limiting toxicities (DLTs) for the age...two weeks to patients with a diverse range of soli...
Other Medicine Technology:Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH) 2Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH) 3Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH) 4Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH) 5Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997 2Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997 3Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997 4
(Date:11/24/2009)...atementbeingPreparedbyLeadingLawFirm,NewTransferAg...e-FirstCall/--AmericanScientificResourcesInc.(Pink...acurrentcorporateupdate. ,, Sincefiling2007and2...ndiligentinaccomplishingadditionalgoals,whichareal...spartofthisongoingprocess,2009thirdquarter(unaudit...
(Date:11/24/2009)...-USNewswire/--ThefollowingshouldbeattributedtoSter...tion: ,, TheW.K.KelloggFoundationcommendsCongre...yandsubstantiallystrengthenoralhealthcareforourmos...ersionofhealthreformrepresentsahighwatermarkforora...ovisionsaimedatimprovingoralhealthcare,whichinclud...
(Date:11/24/2009)... that testing less is OK , , TUESDAY, No...ening has been upended in the past two weeks. ,...rce (USPSTF) just raise the age at which it recomm..., but the American College of Obstetrics and Gynec... spared the inconvenience and possible risks of ce...
(Date:11/24/2009)...m creates numerous challenges for Primary Care doc...—and suggests the need to re-examine reimbur...(Vocus) November 24, 2009 -- The proposed legislat..., to say the least -- with practitioners, consumer...ghing in with their views on what will best &ldquo...
(Date:11/24/2009)...ists offer advice on the topic of most concern to ...ompletely and finally; forsake utterly; to desert....us) November 24, 2009 -- Dr. Suzanne LaCombe and D... is its groundbreaking "The New Paradigm for ...m ( http://www.myshrink.com )., , ,Titled "Ab...
Breaking Medicine News(10 mins):Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3Health News:Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform 2Health News:Recent Cancer Screening Changes Leave Many Confused 2Health News:Recent Cancer Screening Changes Leave Many Confused 3Health News:Recent Cancer Screening Changes Leave Many Confused 4Health News:Jackson & Coker Industry Report Addresses Health Care Reform 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 3Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2
...u can walk at work instead. , , Grand Rapids, Mic...o Work Day. Endorsed by the U.S. Department of He...courages Americans to turn their commute into an e... Disease Control and Prevention, the prevalence of...
...ke and also have an abnormality in the heart,s ele... 90 days than people who do not have abnormal elec..., according to new research. , The study also pro...orst prognosis. The findings are published online ...
...e stomach bug,s activity, research suggests , ...archers say they have found a possible link betwee...train of the E. coli bacterium. , Researchers at t...in, picks up signals when stress hormones are rele...
...term group homes in Los Angeles County after being... still involved with crime or drugs seven years la... The bleak findings suggest there is a need to imp...track juvenile offenders for so long so that littl...
... Medical Innovations, Inc. (NYSE: IMA ), a globa... their health at home through the merger of rapid ... to the extent declared, dividends payable April 1...ctional shares resulting from the dividend. , ,...
... Medical Innovations, Inc. (NYSE: IMA ), a globa... their health at home through the merger of rapid ... that it has entered into a definitive agreement w...ing lateral flow immunoassay diagnostic test kits ...
Other Medicine News:Health News:National Walk to Work Day is April 3 2Health News:National Walk to Work Day is April 3 3Health News:Abnormal EKG can predict death in stroke patients 2Health News:Stress May Encourage E. Coli Illness 2Health News:Study finds most adolescents sent to group homes still involved with drugs/crime seven years later 2Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 2Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 3Health News:Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON 4
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: